Reference : Potential cost-effectiveness for using patient decision aids to guide osteoporosis tr...
Scientific journals : Article
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/201769
Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment
English
Penton, H []
Hiligsmann, M. []
Harrison, M. []
Reginster, Jean-Yves mailto [Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Boonen, A. []
Bansback, N. []
2016
Osteoporosis International
Springer Science & Business Media B.V.
27
2697-2707
Yes (verified by ORBi)
International
0937-941X
1433-2965
Godalming
United Kingdom
[en] Adherence ; Bisphospohonates ; Cost-effectiveness ; Osteoporosis ; Patient decision aid ; Shared decision-making
[en] We use a model to predict whether using a patient
decision aid in patients considering bisphosphonate therapy
would be a good use of health resources. We found that if
the decision aid improved adherence, and only marginally
increased time physicians needed with their patients, then
the decision-aid would be cost-effective.
Introduction Oral bisphosphonates have been shown to reduce
the risk of osteoporotic fracture. Adherence is crucial
but suboptimal. A recent study suggests that a patient decision
aid, which facilitates shared decision-making, could be effective
in increasing adherence to bisphosphonates. But decision
aids come at a cost in terms of additional time spent with
physicians. This study considers the emerging evidence on
the role of patient decision aids in improving adherence to
bisphosphonates and their potential costs to inform future
decision-making and research priorities.
http://hdl.handle.net/2268/201769
10.1007/s00198-016-3596-5

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.pdfPublisher postprint607.77 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.